RHUMBLINE ADVISERS - BLACK DIAMOND THERAPEUTICS I ownership

BLACK DIAMOND THERAPEUTICS I's ticker is BDTX and the CUSIP is 09203E105. A total of 81 filers reported holding BLACK DIAMOND THERAPEUTICS I in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
RHUMBLINE ADVISERS ownership history of BLACK DIAMOND THERAPEUTICS I
ValueSharesWeighting
Q3 2023$1,288
-43.2%
4490.0%0.00%
Q2 2023$2,267
-97.2%
449
-98.5%
0.00%
Q1 2022$81,000
-50.6%
29,064
-5.7%
0.00%
Q4 2021$164,000
-38.3%
30,813
-1.8%
0.00%
Q3 2021$266,000
-28.1%
31,393
+3.5%
0.00%
Q2 2021$370,000
-16.7%
30,318
+65.6%
0.00%
-100.0%
Q1 2021$444,000
-28.6%
18,306
-5.7%
0.00%0.0%
Q4 2020$622,000
+21.0%
19,411
+14.1%
0.00%0.0%
Q3 2020$514,000
-19.4%
17,019
+12.4%
0.00%0.0%
Q2 2020$638,000
+112.0%
15,140
+25.5%
0.00%0.0%
Q1 2020$301,00012,0610.00%
Other shareholders
BLACK DIAMOND THERAPEUTICS I shareholders Q2 2020
NameSharesValueWeighting ↓
NEA Management Company, LLC 3,449,845$110,568,0002.92%
Boxer Capital, LLC 2,014,858$64,576,0002.08%
RA Capital Management 2,589,904$83,006,0001.16%
Artal Group S.A. 1,646,517$52,771,0001.13%
Burrage Capital Management LLC 34,891$1,118,0000.85%
Bellevue Group AG 1,403,000$44,967,0000.52%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 802,511$25,720,0000.51%
Ikarian Capital, LLC 293,941$9,421,0000.42%
Avoro Capital Advisors LLC 640,000$20,512,0000.35%
Logos Global Management LP 123,465$3,957,0000.34%
View complete list of BLACK DIAMOND THERAPEUTICS I shareholders